Please provide your email address to receive an email when new articles are posted on . Age, nulliparity, polyps and shorter sampling intervals may predict endometrial hyperplasia and cancer. Risk ...

August 4, 2010 — Women with complex or atypical endometrial hyperplasia who are prescribed progestin have a 3- to 5-fold diminished risk for the development of endometrial cancer. Hysterectomy risk is ...

Please provide your email address to receive an email when new articles are posted on . Conjugated estrogen/bazedoxifene users had higher endometrial cancer and endometrial hyperplasia rates vs.

Although it might seem reasonable to pronounce women cured after their endometrial hyperplasia regresses from hormonal treatment, researchers caution that long-term monitoring for relapse and cancer ...

Several studies have investigated the mechanisms involved in progestin resistance. Decreased availability of progestin receptors before treatment or alterations in progestin receptor regulatory ...

This page lists all known medications that could potentially lead to 'Endometrial hyperplasia' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

Women with atypical endometrial hyperplasia have an increased risk of developing cancer Researchers from the University of Edinburgh have revealed that improved patient care is needed to reduce cancer ...

The p160 steroid receptor cofactor (SRC) family of coactivators can modulate both ER and PR activity; however, it has recently been demonstrated that in the mouse uterus, SRC-1 is the preferred ...

Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G1 Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2 We conducted a case ...

Reproductive and Sexual Function After Platinum-Based Chemotherapy in Long-Term Ovarian Germ Cell Tumor Survivors: A Gynecologic Oncology Group Study This multicenter prospective study was carried out ...